Fraudulently Obtained Drug Patents Created “Downstream” Fraud on Government Healthcare Programs; United States District Court for the Northern District of California No. 18-cv-03018 JCS, Zachary Silbersher, et al. v. Allergan Inc., et al.

The district court denied the defendants’ motion to dismiss a qui tam case alleging fraud on the U.S. Patent and Trade Office and subsequent violation of the FCA. In short, the defendants argued that patent applications to USPTO were not false claims for payment to the government, but the court sided with the relator, who […]
Must be a Paid Member or a Free Trial Member to Access Content. Members log in here.